How effective is Carvedilol for Malignant Hypertension? (a real world drug study)
Summary:
Overall ratings: 3.7/5 Long term ratings: 5/5
This is a phase IV clinical study of how effective Carvedilol (carvedilol) is for Malignant hypertension and for what kind of people. The study is created by eHealthMe from 3 Carvedilol users and is updated continuously.
What is Carvedilol?
Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,651 Carvedilol users. Check the latest studies of Carvedilol.
What is Malignant hypertension?
Malignant hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage) is found to be associated with 229 drugs and 302 conditions by eHealthMe. Check the latest studies of Malignant hypertension.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
3 people are studied for taking Carvedilol in Malignant hypertension
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Carvedilol effectiveness for Malignant hypertension (number of people):
Overall:
- not at all: 0
- somewhat: 1
- moderate: 0
- high: 1
- very high: 1
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 0
- very high: 1
Gender of people who take Carvedilol for Malignant hypertension *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Carvedilol for Malignant hypertension *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 33.33 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 66.67 %
Who find Carvedilol more effective for Malignant Hypertension?
Gender of people who take Carvedilol for Malignant hypertension *:
- female: 50 %
- male: 50 %
Age of people who take Carvedilol for Malignant hypertension *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 50 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 50 %
* Approximation only. Some reports may have incomplete information.
Do you take Carvedilol?
- You can start a phase IV clinical trial to monitor Carvedilol safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Carvedilol (112,651 reports)
Treatments, associated drugs and conditions:
- Malignant hypertension (1,348 reports)
How the study uses the data?
The study is based on carvedilol (the active ingredients of Carvedilol) and Carvedilol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Magnesium Glycinate and Wellbutrin - a second ago
- Drug interactions of Lorazepam and Nexplanon - 5 seconds ago
- Could Flonase cause Photophobia? - 10 seconds ago
- Could Ambien cause Ageusia? - 10 seconds ago
- Could Lidocaine Viscous cause Cough? - 15 seconds ago
- Could Keflex cause Tinnitus Aggravated? - 16 seconds ago
- Could Doxorubicin Hydrochloride cause Leukocytosis? - 17 seconds ago
- Drug interactions of Magnesium and Galafold - 18 seconds ago
- Drug interactions of Niacin and Synthroid - 24 seconds ago
- Could Doxorubicin Hydrochloride cause Depressed Mood? - 25 seconds ago